baber/WOPTO huggingface dataset:
Patent CA-3120907-A1 (CA)
Inventor: JESPERSEN UFFE
IPC: E04B9/02
Filed: 2019-11-28
Abstract: La présente invention concerne un système de construction comprenant un espace de construction défini par un plafond structural (2) et un plancher (3) d'un bâtiment, et un système de plafond (4). Le système de plafond (4) comprend un plafond suspendu perméable à l'air (5) disposé au-dessous du plafond structural (2), un espace de plénum (7) étant formé entre le plafond suspendu (5) et le plafond structural (2) et un espace de plancher (8) étant formé entre le plancher (3) et le plafond suspendu (5), et une pluralité de sections de paroi de séparation (6). La pluralité de sections de paroi de séparation (6) est disposée dans l'espace de plénum (7) s'étendant entre le plafond structural (2) et le plafond suspendu (5) ; et forme une pluralité de modules de plénum (9) répartis sur l'ensemble de l'espace de plénum (7). Chacun de la pluralité de modules de plénum (9) comprend un équipement, l'équipement de chaque module de plénum (9) comprenant un dispositif d'air d'alimentation (12) destiné à distribuer de l'air d'alimentation au module de plénum y étant associé (9) en vue de sa mise sous pression de sorte que l'air d'alimentation distribué au module de plénum (9) est fourni à l'espace de plancher (8) à travers le plafond suspendu perméable à l'air (5).
Patent CA-3121045-A1 (CA)
Title: Processes for preparing nitrosylated propanediols, compositions comprising the same, and medical uses thereof
Inventor: AGVALD PER HAKAN
IPC: C07C201/04
Filed: 2019-11-27
Abstract: The present invention relates to a novel process for the synthesis of mono- and bis-nitrosylated propanediols, as well as novel compositions and pharmaceutical formulations comprising said compounds. The process proceeds by reacting a corresponding propanediol that is not nitrosylated with a source of nitrite, optionally in the presence of a suitable acid. Wherein, when the source of nitrite is an organic nitrite, reacting step is performed in a suitable organic solvent, and when the source of nitrite is an inorganic nitrite, the reacting step is performed in a bi-phasic solvent mixture comprising an aqueous phase and a non-aqueous phase. The invention also relates to methods of treating a condition wherein administration of nitric oxide (NO) has a beneficial effect by administering said compounds, compositions or formulations.
Patent CA-3122135-A1 (CA)
Title: Anti-claudin antibodies and uses thereof
Inventor: LI YONG
IPC: C07K16/28
Filed: 2019-12-06
Abstract: Disclosed herein are anti-Claudin 18.2 antibodies and pharmaceutical compositions comprising the same. In some embodiments, also described herein are methods of treating a subject having a cancer with an anti-Claudin 18.2 antibody and methods of inducing cell kill effect with an anti-Claudin 18.2 antibody.
Patent CA-3122229-A1 (CA)
Title: Composition for and method of facilitating corneal tissue repair
Inventor: TAN TAO
IPC: A61K9/00
Filed: 2019-10-10
Abstract: Compositions for and methods of treating corneal injury, among other tissue of or around the eye, are provided. Said compositions comprise MG53 or express MG53. Said compositions can he used for treating chronic or acute injured tissue of the eye or orbit of the eye and can he administered systemically, locally, or both.
Patent CA-3127742-A1 (CA)
Inventor: ROGERS GRAEME
IPC: A61K38/16
Filed: 2020-01-24
Abstract: The present disclosure provides molecules which modulate cell growth. These molecules include those that bind carbohydrates and may find application in the treatment and/or prevention of cell proliferation and/or differentiation disorders, cancer and/or it's migration and/or spread.
Patent CA-3129805-A1 (CA)
Title: Cartridge for an aerosol-generating system
Inventor: MALGAT ALEXANDRE
IPC: H05B3/34
Filed: 2014-12-15
Abstract: A cartridge for use in an aerosol-generating system is described. The cartridge comprises a liquid storage portion comprising a housing (24) for holding a liquid aerosol-forming substrate, wherein the liquid storage portion comprises at least two parts in fluid communication with each other. The first part (32) of the liquid storage portion comprises a heater assembly (46), a first capillary material (36), provided in contact with the heater assembly, and a second capillary material (38) in contact with the first capillary material and spaced apart from the heater assembly by the first capillary material. The second part (34) of the liquid storage portion comprises a container for example a tank for holding aerosol-forming substrate in liquid form and supplying the liquid to the second capillary material.
Patent CA-3130753-A1 (CA)
Inventor: MCKINZIE KYLE K
IPC: A01B63/16
Filed: 2021-09-14
Abstract: A method of controlling an agricultural work system includes defining a wheelbase of the traction unit and defining at least one implement dimension of the drawn implement relative to the traction unit. A pitch angle of the traction unit about a central transverse axis is sensed relative to a horizontal reference plane as the traction unit moves over a terrain feature of a ground surface. A  controller may then generate an elevation profile of the ground surface from the sensed pitch angle and the wheelbase of the traction unit. The controller may then control or actuate an adjustable component to adjust a ground clearance between the drawn implement and the ground surface to avoid contact between the drawn implement and the terrain feature as the drawn implement moves over the terrain feature.
Patent CA-3132010-A1 (CA)
Title: Systems and methods for producing a privacy-protected video clip
Inventor: MATUSEK FLORIAN
IPC: G08B13/194
Filed: 2021-09-27
Abstract: Producing a privacy-protected video clip in a video management system includes retrieving a selected video clip constituting at least a portion of a stored video stream;  obtaining segments of the video clip which are spaced apart in time and have a total length equal to a defined time period; combining the obtained segments of the video clip to form a background training clip; and processing the background training clip, or the separate segments, to produce a background model. The video clip is processed to produce a privacy-protected video clip, such that, for each image the video clip, the processing includes performing background subtraction, using the background model, to define foreground regions, and obscuring the defined foreground regions.
Patent CA-3132025-A1 (CA)
Inventor: AYRES LEE
IPC: A61L31/18
Filed: 2020-03-26
Abstract: The invention relates to the use of an echogenic coating composition on a medical device to be inserted into a body at depths greater than 5 cm, comprising: (i) a polymer matrix and (ii) an amount of ultrasound-reflective microparticles having a diameter that is at least 10 and at most 250 µm in size, with a defined relationship between the particle size, expressed as D 50, and the surface density. The invention further relates to a method for ultrasound detection of a medical device at a scan depth greater than 5 cm, by providing the medical device with the echogenic coating composition and to an echogenic assembly comprising the medical device and a convex probe.
Patent CA-3133243-A1 (CA)
Inventor: AZALI STEPHANIE
IPC: A61P9/00
Filed: 2020-03-12
Abstract: Provided herein are free base crystalline forms, crystalline salts, solvates, amorphous free base, and cocrystals of Compound A.
Patent CA-3134439-A1 (CA)
Title: Variants d'interleukine-2 a activite biologique modifiee
Inventor: PIAGGIO ELIANE
IPC: A61K38/20
Filed: 2020-03-27
Abstract: L'invention concerne des variants d'interleukine-2 (IL-2) pour la prévention ou le traitement de troubles immunitaires, comprenant sans limitations des maladies inflammatoires et infectieuses chroniques ou aiguës, auto-immunes, allergiques ; la maladie du greffon contre l'hôte ; le rejet de greffe et le cancer. L'invention concerne également l'utilisation desdits variants d'IL-2 pour le criblage d'anticorps anti-IL-2 avec une activité cellulaire pro-T effectrice ou pro-T-régulatrice.
Patent CA-3137901-A1 (CA)
Title: Heterocyclic inhibitors of tyrosine kinase
Inventor: HEYMACH JOHN
IPC: C07D471/04
Filed: 2020-04-24
Abstract: The present disclosure relates to heterocyclic compounds and methods which may be useful as inhibitors of HER2 or EGFR for the treatment or prevention of disease, including cancer.
Patent CA-3138125-A1 (CA)
Title: Trench box and method of assembly
Inventor: FOLEY JAMES
IPC: E02D17/08
Filed: 2016-07-22
Abstract: A trench box has first and second side panels connected in parallel spaced relation by first and second lateral supports. Each lateral support comprises connection points at each end of each lateral support that connect the side panels to the lateral supports. The connection points maintain the side panels in parallel spaced relation and the lateral supports in parallel spaced relation between tbc side panels. Each connection point complises a pivot connection that permits pivotal movement of the side panels relative to the lateral supports about a pivot axis, and a releasable connection spaced fi-om the pivot connection in a direction perpendicular to tbe pivot axis. The releasable connection is selectively releasable to pennit the respective first or second side panel to pivot about the pivot axis such that the panels are not parallel_
Patent CA-3139078-A1 (CA)
Inventor: SKJAVELAND OYVIND
IPC: G01V1/28
Filed: 2020-04-29
Abstract: Un procédé d'analyse de données sismiques à partir d'une structure géologique comprend les étapes consistant à : déterminer un ensemble de pavés à partir d'un cube de données de données sismiques ; et déterminer quels pavés de l'ensemble de pavés peuvent être regroupés en un ou plusieurs groupes de pavés.
Patent CA-3139093-A1 (CA)
Inventor: ZACHER RUDOLPH F
IPC: A61F2/16
Filed: 2020-06-08
Abstract: L'invention concerne un piston d'injecteur de LIO ayant des bras de compression de LIO.
Patent CA-3141217-A1 (CA)
Title: Switching system for edr water purifier with multiple solenoid valves
Inventor: DING ALLEN
IPC: C02F1/469
Filed: 2021-12-07
Abstract: A switching system has two inlet ends (1, 2), two outlet ends (3, 4), and an EDR membrane stack (5). Each inlet end (1, 2) and each outlet end (3, 4) are connected to both a primary branch (11, 21, 31, 41) and a secondary branch (12, 22, 32, 42). Solenoid valves (111, 121, 211, 221, 311, 321, 411, 421) are mounted on each primary branch and secondary branch. The EDR membrane stack has two inlets (51, 52) respectively connected to the primary and the secondary branch of the two inlet ends, two outlets (53, 54) respectively connected to the primary and the secondary branch of the two outlet ends, and two electrodes (55, 56). The polarity of the two electrodes is interchangeable. The two water flows that pass through the EDR membrane stack are interchangeable.
Patent CA-3141446-A1 (CA)
Title: Safe power beam startup
Inventor: NUGENT THOMAS J
IPC: H04B10/80
Filed: 2020-05-21
Abstract: A remote power system includes a remote power transmitter arranged to output a power beam in a startup mode and a remote power receiver arranged to receive the power beam. The remote power receiver has a plurality of photovoltaic (PV) cells (or other power converters) mounted to generate electrical power from energy in the power beam, startup power monitoring (SPM) logic to determine, based on electrical power generated by each of the plurality of PV cells, whether or not the remote power transmitter can operate in a high-flux mode, and a receiver-based transmitter circuit arranged to communicate an indication that the remote power transmitter can operate in the high-flux mode.
Patent CA-3141494-A1 (CA)
Title: Compositions and methods for treatment of hemochromatosis
Inventor: DAUGHERTY SEAN CHRISTOPHER
IPC: C12N5/071
Filed: 2020-05-22
Abstract: This application provides polynucleotides comprising a coding sequence for a functionally active hereditary hemochromatosis protein (HFE) or a functionally active fragment thereof. The invention further provides compositions comprising said polynucleotides and their use in methods of preventing or treating hemochromatosis in a subject.
Patent CA-3142147-A1 (CA)
Title: Alk7 binding proteins and uses thereof
Inventor: KNOPF JOHN
IPC: A61P3/04
Filed: 2020-05-29
Abstract: This disclosure provides ALK7-binding proteins such as anti-ALK7 antibodies, and compositions and methods for making the ALK7-binding proteins. In certain embodiments, the ALK7-binding proteins inhibit or antagonize ALK7 activity. In addition, the disclosure provides compositions and methods for diagnosing and treating overweight, obesity, diabetes, overweight, obesity, type 2 diabetes, and their associated conditions; metabolic disorders, and other diseases or conditions that can be treated, prevented or ameliorated by targeting ALK7.
Patent CA-3142439-A1 (CA)
Title: Compositions and methods for bone repair and bone health
Inventor: VARGHESE SHYNI
IPC: A61K47/36
Filed: 2020-06-03
Abstract: The present disclosure relates to polymer-based biomaterials for the systemic or localized delivery of osteoanabolic molecules, and their use in methods for treating and/or preventing bone degeneration and for promoting bone regeneration. In one aspect, the present invention provides a biomaterial comprising a polymer and a bioactive molecule binding moiety. In certain embodiments of the first aspect of the invention, the bioactive molecule binding moiety is an osteoanabolic molecule binding moiety.
Patent CA-3143512-A1 (CA)
Title: Fruit preps and other sweet sauces comprising sugar reduction solutions and starch
Inventor: ICOZ DIDEM
IPC: A23L29/30
Filed: 2020-06-24
Abstract: Described herein are food product compositions comprising a sugar reduction solution comprising a rare sugar, xylo-oligosaccharide, or a combination thereof as a partial or complete replacement for a nutritive sweetener. Various food products containing compositions described herein and methods of making the same are also described. Beneficially, compositions comprising the sugar reduction solution described herein are more stable compositions that do not exhibit syneresis and/or enable the starch content contained therein to be reduced in comparison to full-sugar starch-containing products.
Patent CA-3144746-A1 (CA)
Inventor: KUTER-ARNEBECK OTTOLEO
IPC: H02J7/00
Filed: 2022-01-05
Abstract: A storage unit, such as, for example, a toolbox or cabinet, having a power strip with power terminals adapted to operably couple to and provide electricity to a connected device. The storage unit further including an interrogation module adapted to interrogate or monitor electric supply information about electricity supplied to the connected devices via the power terminals, a computation module operably coupled to the interrogation module, and adapted to receive electric supply data signals from the interrogation module to determine a status of the connected device by comparing the electric supply data signals and usage characteristics of the connected device, and a communication module adapted to receive status data signals from the computation module and communicate the status data signals to a remote computing device.
Patent CA-3145861-A1 (CA)
Inventor: LIU PENG
IPC: A61K51/04
Filed: 2020-08-07
Abstract: L'invention concerne une nouvelle classe de polymères marqueurs de masse qui comprennent des isotopes métalliques enrichis tels que des marqueurs de masse de zirconium et d'hafnium. La chimie de ces nouveaux marqueurs de masse est différente de celle des marqueurs de masse de lanthanide, et ouvre de nouveaux canaux de masse qui peuvent être utilisés en cytométrie de masse. Ces polymères peuvent être utilisés pour la cytométrie de masse, l'administration thérapeutique d'un isotope radioactif, ou le criblage d'un isotope thérapeutique. Certains aspects concernent un kit, un procédé de fabrication et une méthode d'utilisation d'un polymère, d'une composition isotopique, ou des deux. Un kit peut comprendre un polymère. Le polymère peut comprendre des groupes pendants qui chélatent un isotope enrichi, tel que le zirconium et/ou l'hafnium. Le kit peut comprendre une composition isotopique comprenant un isotope enrichi en zirconium ou en hafnium. Les polymères peuvent être conjugués à un matériau biologiquement actif. D'autres aspects peuvent également concerner la fabrication d'un kit. Certains aspects concernent l'utilisation d'un kit, par exemple, pour la cytométrie de masse.
Patent CA-3146106-A1 (CA)
Title: Double wall folding chair and method for use
Inventor: BOTTRELL JAMES
IPC: A47C7/16
Filed: 2022-01-19
Abstract: A folding chair is described. It includes a double-wall single mold chair seat, a double-walled chair back, and a hinge that joins the seat and the back. As a result, the seat and the back can open and close relative to each other. A method for use includes detaching the folding chair from a support frame and folding the chair back against the seat to form a flat folded configuration.
Patent CA-3146386-A1 (CA)
Title: Pharmaceutical composition comprising a tetrahydropyrazolopyrimidinone compound
Inventor: AMBUEHL MICHAEL
IPC: A61K47/22
Filed: 2020-07-08
Abstract: The invention relates to pharmaceutical compositions, which are self-emulsifying, self-microemulsifying, or self- nanoemulsifying in aqueous medium, comprising the compound: 2-(2,2-Difluoro-propyl)-5-[1-(2-fluoro-6-methyl- phenyl)-piperidin-4-yl]-7-(2-trifluoromethyl-benzyl)-2,4,5,7-tetrahydro-pyrazolo[3,4-d]pyrimidin-6-one and a mixture of excipients comprising one or more lipophilic excipient(s); one or more hydrophilic surfactant(s); and optionally one or more hydrophilic co-solvent(s). The invention further relates to a crystalline form of said compound, and its use for the preparation of the present compositions. The invention further relates to pharmaceutical uses of the compositions for the prevention / prophylaxis or treatment of diseases and disorders related to pathogenic events associated with elevated levels of C5a and/or with C5aR activation.
Patent CA-3149474-A1 (CA)
Title: Dead-end sap line connector and sap collection system comprising said dead-end sap line connector
Inventor: LAPIERRE CARL
IPC: A01G23/10
Filed: 2022-02-18
Abstract: A dead-end sap line connector for a sap collection system is provided. The dead-end sap line connector comprises a fluid transfer body having interconnected walls defining a hollow inner chamber being in fluid communication with a plurality of fittings each extending from one of said walls; a first fitting being engageable with the drop line; and a second fitting extending in a direction orthogonal to the first fitting and being engageable with the lateral line. The dead-end sap line connector further comprises a sealing member extending from one of said walls in a direction opposite to said first fitting, and a plugged fitting extending from one of said walls in a direction opposite to said second fitting. A sap collection system comprising said dead-end sap line connector is also provided. Moreover, an alternative dead-end sap line connector (and a system comprising said dead-end sap line connector) is also provided.
Patent CA-3151055-A1 (CA)
Inventor: DALLAIRE-DEMERS PIERRE-LUC
IPC: B82Y10/00
Filed: 2020-09-26
Abstract: A quantum computer or a hybrid quantum-classical (HQC) computer leverages the power of noisy intermediate-scale quantum (NISQ) superconducting quantum processors at and/or beyond the suprernacy regirne to evaluate the ground state energy of an electronic structure Hamiltonian.
Patent CA-3152990-A1 (CA)
Inventor: IRIGARAY SEBASTIEN
IPC: A61K38/17
Filed: 2020-09-04
Abstract: La présente invention concerne des protéines de fusion appropriées pour être utilisées comme médicament ou outil de recherche. Les utilisations thérapeutiques des protéines de fusion peuvent comprendre la prévention ou le traitement d'un organe entraîné par un système immunitaire et inflammatoire aigu ou chronique et des troubles microvasculaires, par exemple, une lésion rénale aiguë, un infarctus aigu du myocarde, une détresse respiratoire aiguë ou une fibrose pulmonaire obstructive chronique et d'autres lésions d'organe résultant d'un traumatisme tissulaire et d'une lésion aiguë et chronique.
Patent CA-3153475-A1 (CA)
Inventor: DEMUYNCK RANDOLPH C
IPC: F21V17/14
Filed: 2020-11-18
Abstract: L'invention concerne des couplages d'optique, comprenant des bagues d'arrêt d'optique, qui nécessitent moins d'outillage ou aucun outillage pour une installation d'optique sur des luminaires. En résumé, une bague d'arrêt servant au couplage d'une optique à un luminaire comprend des ensembles d'alignement radial comprenant une base, et une saillie s'étendant depuis une surface de la base destinée à venir en prise avec un ensemble de couplage de l'optique. Au moins un ensemble de blocage radial est décalé par rapport aux ensembles d'alignement radial, l'ensemble de blocage radial comprenant une saillie verticale destinée à venir en prise avec une ouverture de l'ensemble de couplage d'optique et à bloquer la rotation de l'optique par rapport aux ensembles d'alignement radial.
Patent CA-3155388-A1 (CA)
Inventor: LISKEY CARL WILLIAM
IPC: C08G73/10
Filed: 2020-11-05
Abstract: Rigid polyurethane or polyisocyanurate foams, polyester polyols used to produce them, and methods for formulating the foams are disclosed. The foams comprise a reaction product of a polyisocyanate, a polyester polyol, water, a surfactant, a catalyst and optional ingredients. The polyester polyols comprise a phthalimide-containing polyacid, a phthalimide-containing polyol, or a combination thereof. Rigid foams produced from the polyester polyols exhibit higher thermal stability and/or greater intumescence when compared with foams made from other polyester polyols. The phthalimide-containing polyester polyols should allow formulators to improve the flammability performance of rigid foams with reduced levels of flame retardants and/or lower index and should facilitate the production of thinner insulation panels.
Patent CA-3156096-A1 (CA)
Inventor: FINLAY WILLIAM JAMES JONATHAN
IPC: C07K16/28
Filed: 2020-10-09
Abstract: L'invention concerne des molécules d'anticorps qui se lient de manière spécifique au récepteur de mort cellulaire programmée 1 (PD1) et au récepteur du facteur de croissance de l'endothélium vasculaire 2 (VEGFR2), ainsi que des molécules d'acide nucléique, des vecteurs et des cellules hôtes associés. L'invention concerne également des utilisations médicales de telles molécules d'anticorps.
Patent CA-3156812-A1 (CA)
Title: Formulations d'anticorps anti-connexine
Inventor: ZHANG YANFENG
IPC: A61K38/04
Filed: 2020-10-02
Abstract: La présente invention concerne des compositions pharmaceutiques et des méthodes de traitement d'une maladie ou d'un état associé à une ouverture insuffisante d'hémicanaux Cx43 dans des ostéocytes, de préférence pour le traitement du cancer, de la métastase cancéreuse, de l'ostéosarcome, de l'ostéoporose ou de l'ostéopénie.
Patent CA-3157332-A1 (CA)
Inventor: BACON DAVID L
IPC: E04G11/50
Filed: 2020-10-06
Abstract: An adjustable beam may include an elongate member extending between a first end and a second end, a first connector pivotably coupled to the first end, and a second connector pivotably coupled to the second end. The first and second connectors each are configured to be releasably coupled to neighboring supporting beams and other adjustable beams.
Patent CA-3157562-A1 (CA)
Inventor: Cirik Ali Cagatay
IPC: H04W52/24
Filed: 2022-04-26
Abstract: A transmission power for a wireless communication may be determined based on one or more criteria. A default transmission power may be based on one or more default transmission power control parameters indicated by a base station. One or more default transmission power control parameters may be determined, for a transmission by a wireless device, based on whether the transmission is via a serving cell or via a non-serving cell.